Suppr超能文献

系统性硬化症患者输注伊洛前列素后指端血流持续增加。

Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis.

作者信息

Rademaker M, Thomas R H, Provost G, Beacham J A, Cooke E D, Kirby J D

机构信息

Department of Dermatology, St Bartholomew's Hospital, West Smithfield, London, UK.

出版信息

Postgrad Med J. 1987 Aug;63(742):617-20. doi: 10.1136/pgmj.63.742.617.

Abstract

Thirteen patients with Raynaud's phenomenon secondary to systemic sclerosis received three 8-hour infusions of a synthetic prostacyclin analogue (Iloprost) on consecutive days and were followed-up over a period of 10 weeks during the winter of 1985/86. Six weeks after infusion, digital peripheral vascular resistance had fallen (P less than 0.05) and dicrotic notch proportion of pulse amplitude increased (P less than 0.05). Digital blood flow and pulse amplitude (measured by photoplethymography) were also increased but did not reach statistical significance. The trend of improvement in these blood flow parameters was still evident after 10 weeks. The number of cutaneous lesions (digital ulcers, etc) fell from 26 lesions before infusion to only 7 lesions by the end of the study, confirming the subjective improvement reported by the patients.

摘要

13例继发于系统性硬化症的雷诺现象患者在连续3天接受了3次8小时的合成前列环素类似物(依洛前列素)静脉输注,并于1985/1986年冬季进行了为期10周的随访。输注6周后,指端外周血管阻力下降(P<0.05),脉搏波幅的重搏波切迹比例增加(P<0.05)。指端血流和脉搏波幅(通过光电容积描记法测量)也有所增加,但未达到统计学显著性。10周后这些血流参数的改善趋势仍然明显。皮肤病变(指端溃疡等)的数量从输注前的26处减少至研究结束时仅7处,证实了患者报告的主观改善情况。

相似文献

1
Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis.
Postgrad Med J. 1987 Aug;63(742):617-20. doi: 10.1136/pgmj.63.742.617.
5
Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogue.
Br J Rheumatol. 1988 Jun;27(3):220-6. doi: 10.1093/rheumatology/27.3.220.
9
[Treatment of Raynaud's phenomenon in scleroderma with a new stable prostacyclin derivative].
Dtsch Med Wochenschr. 1984 Sep 21;109(38):1433-8. doi: 10.1055/s-2008-1069390.

引用本文的文献

2
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review.
Rheumatology (Oxford). 2023 Dec 1;62(12):3785-3800. doi: 10.1093/rheumatology/kead289.
3
Raynaud's Phenomenon: A Brief Review of the Underlying Mechanisms.
Front Pharmacol. 2016 Nov 16;7:438. doi: 10.3389/fphar.2016.00438. eCollection 2016.
4
Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries.
Int J Nanomedicine. 2014 Jul 7;9:3249-61. doi: 10.2147/IJN.S63190. eCollection 2014.
6
Large leg ulcers due to autoimmune diseases.
Med Sci Monit. 2011 Jan;17(1):CS1-7. doi: 10.12659/msm.881308.
8
[Treatment of therapy-resistant acral ulcers with iloprost].
Hautarzt. 2004 Dec;55(12):1150-3. doi: 10.1007/s00105-004-0844-y.
9
Long-term evaluation of lung function in patients affected by scleroderma treated with cyclic iloprost infusions.
Rheumatol Int. 2005 May;25(4):250-4. doi: 10.1007/s00296-004-0439-z. Epub 2004 Feb 13.
10
[Iloprost therapy in systemic sclerosis].
Hautarzt. 2003 Sep;54(9):845-51. doi: 10.1007/s00105-003-0578-2.

本文引用的文献

1
Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2).
Br J Dermatol. 1982 Jan;106(1):81-9. doi: 10.1111/j.1365-2133.1982.tb00905.x.
3
Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial.
Lancet. 1983 Feb 12;1(8320):315-7. doi: 10.1016/s0140-6736(83)91625-2.
6
Photoplethysmography of the distal pulp in the assessment of the vasospastic hand.
Angiology. 1985 Jan;36(1):33-40. doi: 10.1177/000331978503600106.
7
Prostaglandin E1 vasospastic disease and thermography.
Ann Rheum Dis. 1985 Feb;44(2):73-8. doi: 10.1136/ard.44.2.73.
8
Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells.
Br J Pharmacol. 1986 Apr;87(4):685-94. doi: 10.1111/j.1476-5381.1986.tb14586.x.
9
Treatment of childhood Raynaud's disease by transdermal prostaglandin E2 analogue.
Lancet. 1985 Jul 6;2(8445):50. doi: 10.1016/s0140-6736(85)90108-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验